RECTOSIGMOID CANCER RECURRENT

RECTOSIGMOID CANCER RECURRENT was reported 8 times

RECTOSIGMOID CANCER RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aromatase Inhibitor [EPC] 3 0.0000
1 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
2 Microtubule Inhibitor [EPC] 2 0.0000
3 Platinum-based Drug [EPC] 2 0.0000
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
5 Kinase Inhibitor [EPC] 3 0.0000
6 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
7 Vitamin D [EPC] 1 0.0000
8 Vitamin B12 [EPC] 1 0.0000
9 Vitamin C [EPC] 1 0.0000
10 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
11 Atypical Antipsychotic [EPC] 1 0.0000
12 Proton Pump Inhibitor [EPC] 1 0.0000
13 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
14 Corticosteroid [EPC] 1 0.0000